AIM ImmunoTech Inc. — Director's Dealing 2021

Dec 13, 2021

SEC Form 4/A — Form 4/A

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2021-12-13

Reporting Person: Equels Thomas K (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-13	Common Stock	A	21552	$1.16	Acquired	300789	Direct

Footnotes

F1: Form amended to include reporting person is a director and officer.